AGUZZI, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 200
EU - Europa 170
AS - Asia 87
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 466
Nazione #
US - Stati Uniti d'America 199
CN - Cina 59
IT - Italia 33
DE - Germania 27
SE - Svezia 25
IE - Irlanda 19
AT - Austria 17
JP - Giappone 14
FR - Francia 13
FI - Finlandia 10
RU - Federazione Russa 10
SN - Senegal 7
GB - Regno Unito 4
IN - India 4
UA - Ucraina 4
PL - Polonia 3
ID - Indonesia 2
KR - Corea 2
TW - Taiwan 2
UZ - Uzbekistan 2
VN - Vietnam 2
AP - ???statistics.table.value.countryCode.AP??? 1
CA - Canada 1
CZ - Repubblica Ceca 1
ES - Italia 1
EU - Europa 1
LT - Lituania 1
LU - Lussemburgo 1
RO - Romania 1
Totale 466
Città #
Beijing 47
Chandler 40
Dublin 19
Torino 18
Vienna 17
Nyköping 14
Ashburn 13
Villeurbanne 13
Dearborn 10
Fremont 8
Houston 8
Medford 8
Fairfield 6
Princeton 6
Alessandria 5
Wilmington 5
Woodbridge 5
Jacksonville 3
Nanjing 3
Norwalk 3
Radomsko 3
Seattle 3
Villanova 3
Ann Arbor 2
Dong Ket 2
Florence 2
New Taipei 2
New York 2
Redwood City 2
Rome 2
Wuhan 2
Absecon 1
Boardman 1
Bucharest 1
Chatteris 1
Chennai 1
Costa Mesa 1
Durham 1
Düsseldorf 1
Guiyang 1
Hangzhou 1
Hebei 1
Helsinki 1
Hyderabad 1
Jiaxing 1
Luxembourg 1
Madrid 1
Manchester 1
Mega 1
Phoenix 1
Prague 1
Quzhou 1
San Jose 1
San Mateo 1
Shaoxing 1
Stockholm 1
Toronto 1
Upper Marlboro 1
Vilnius 1
Washington 1
Totale 305
Nome #
Retrospective analysis of 260 patients with essential thrombocythemia: iwg-mrt (ipset model; passamonti et al, blood 2012) prognostic score is a good predictor of survival 121
Prognostic value of JAK2V617F, CALR and MPL mutational status on outcome and thrombotic risk in a retrospective cohort of 138 patients with Essential THrombocythemia 93
IMATINIB DISCOTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS ON 28 UNSELECTED PATIENTS 81
Long-term therapy-free remission in a patient with platelet-derived growth factor receptor beta-rearranged myeloproliferative neoplasm. 73
Treatment-free remission in chronic myeloid leukemia harboring atypical BCRABL1 transcripts 60
How many patients can proceed from chronic myeloid leukaemia diagnosis to deep molecular response and long-lasting imatinib discontinuation? A real life experience 55
Totale 483
Categoria #
all - tutte 1.323
article - articoli 0
book - libri 0
conference - conferenze 688
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.011


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 0 4 1 4
2019/202033 0 0 0 6 1 7 5 0 1 6 4 3
2020/202181 3 6 9 7 4 3 7 4 5 2 21 10
2021/202251 3 0 1 3 1 2 3 1 3 1 24 9
2022/2023109 8 10 2 10 10 32 4 10 8 2 13 0
2023/202437 2 15 1 3 3 10 0 3 0 0 0 0
Totale 483